Morjani H - Search Results

1

Thiazolidinone-linked1,2,3-triazoles with monoterpenic skeleton as new potential anticancer agents: Design, synthesis and molecular docking studies.

Oubella A, El Mansouri AE, Fawzi M, Bimoussa A, Laamari Y, Auhmani A, Morjani H, Robert A, Riahi A, Youssef Ait Itto M. Oubella A, et al. Among authors: morjani h. Bioorg Chem. 2021 Oct;115:105184. doi: 10.1016/j.bioorg.2021.105184. Epub 2021 Jul 20. Bioorg Chem. 2021. PMID: 34333421 Review.

2

Design, synthesis, biological evaluation and molecular docking of new uracil analogs-1,2,4-oxadiazole hybrids as potential anticancer agents.

El Mansouri AE, Oubella A, Maatallah M, AitItto MY, Zahouily M, Morjani H, Lazrek HB. El Mansouri AE, et al. Among authors: morjani h. Bioorg Med Chem Lett. 2020 Oct 1;30(19):127438. doi: 10.1016/j.bmcl.2020.127438. Epub 2020 Jul 28. Bioorg Med Chem Lett. 2020. PMID: 32736079

3

Design, synthesis, biological evaluation and molecular docking of new 1,3,4-oxadiazole homonucleosides and their double-headed analogs as antitumor agents.

El Mansouri AE, Oubella A, Mehdi A, AitItto MY, Zahouily M, Morjani H, Lazrek HB. El Mansouri AE, et al. Among authors: morjani h. Bioorg Chem. 2021 Mar;108:104558. doi: 10.1016/j.bioorg.2020.104558. Epub 2020 Dec 15. Bioorg Chem. 2021. PMID: 33358270

4

Newly synthesized (R)-carvone-derived 1,2,3-triazoles: structural, mechanistic, cytotoxic and molecular docking studies.

Hachim ME, Oubella A, Byadi S, Fawzi M, Laamari Y, Bahsis L, Aboulmouhajir A, Morjani H, Podlipnik Č, Auhmani A, Ait Itto MY. Hachim ME, et al. Among authors: morjani h. J Biomol Struct Dyn. 2022 Oct;40(16):7205-7217. doi: 10.1080/07391102.2021.1894984. Epub 2021 Mar 15. J Biomol Struct Dyn. 2022. PMID: 33719863

5

Discovery of novel furo[2,3-d]pyrimidin-2-one-1,3,4-oxadiazole hybrid derivatives as dual antiviral and anticancer agents that induce apoptosis.

El Mansouri AE, Oubella A, Dânoun K, Ahmad M, Neyts J, Jochmans D, Snoeck R, Andrei G, Morjani H, Zahouily M, Lazrek HB. El Mansouri AE, et al. Among authors: morjani h. Arch Pharm (Weinheim). 2021 Oct;354(10):e2100146. doi: 10.1002/ardp.202100146. Epub 2021 Jun 15. Arch Pharm (Weinheim). 2021. PMID: 34128255

6

Design, Hemiysnthesis, crystal structure and anticancer activity of 1, 2, 3-triazoles derivatives of totarol.

Laamari Y, Oubella A, Bimoussa A, El Mansouri AE, Ketatni EM, Mentre O, Ait Itto MY, Morjani H, Khouili M, Auhmani A. Laamari Y, et al. Among authors: morjani h. Bioorg Chem. 2021 Oct;115:105165. doi: 10.1016/j.bioorg.2021.105165. Epub 2021 Jul 14. Bioorg Chem. 2021. PMID: 34298240

7

Cytotoxic and apoptotic effects of some (R)-carvone-isoxazoline derivatives on human fibrosarcoma and carcinoma cells: experimental evaluation for cytotoxicity, molecular docking and molecular dynamics studies.

Oubella A, Bimoussa A, Byadi S, Laamari Y, Fawzi M, N'ait Ousidi A, Oblak D, Auhmani A, Riahi A, Morjani H, Ait Itto MY. Oubella A, et al. Among authors: morjani h. J Biomol Struct Dyn. 2023 Mar;41(5):1930-1943. doi: 10.1080/07391102.2022.2025903. Epub 2022 Jan 11. J Biomol Struct Dyn. 2023. PMID: 35014592

8

New 1,2,3-Triazoles from (R)-Carvone: Synthesis, DFT Mechanistic Study and In Vitro Cytotoxic Evaluation.

Oubella A, Bimoussa A, N'ait Oussidi A, Fawzi M, Auhmani A, Morjani H, Riahi A, Esseffar M, Parish C, Ait Itto MY. Oubella A, et al. Among authors: morjani h. Molecules. 2022 Jan 25;27(3):769. doi: 10.3390/molecules27030769. Molecules. 2022. PMID: 35164037 Free PMC article.

9

Chemical profiling, cytotoxic activities through apoptosis induction in human fibrosarcoma and carcinoma cells, and molecular docking of some 1,2,3-triazole-isoxazoline hybrids using the eugenol as a precursors.

Oubella A, Taia A, Byadi S, Ait Lahcen M, Bimoussa A, Essaber M, Podlipnik C, Morjani H, Ait Itto MY, Aatif A. Oubella A, et al. Among authors: morjani h. J Biomol Struct Dyn. 2023 Apr;41(7):2759-2771. doi: 10.1080/07391102.2022.2037466. Epub 2022 Feb 17. J Biomol Struct Dyn. 2023. PMID: 35174765

10

Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: In vitro and in silico analysis.

Fawzi M, Oubella A, Bimoussa A, Bamou FZ, Khdar ZA, Auhmani A, Riahi A, Robert A, Morjani H, Itto MYA. Fawzi M, et al. Among authors: morjani h. Comput Biol Chem. 2022 Jun;98:107666. doi: 10.1016/j.compbiolchem.2022.107666. Epub 2022 Mar 24. Comput Biol Chem. 2022. PMID: 35381466

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

130 results

Search Page